课题基金 / 基金详情

MECHANISMS OF DIFFERENTIAL SLEEPINESS IN SLEEP APNEA

MECHANISMS OF DIFFERENTIAL SLEEPINESS IN SLEEP APNEA
睡眠呼吸暂停中不同睡眠的机制
批准号:
7510339
负责人:
TERRI Elizabeth WEAVER
金额:
$49.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

TERRI Elizabeth WEAVER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this proposal is to explore potential operating mechanisms in the differential sleepiness observed in patients with equivalent degrees of obstructive sleep apnea (OSA). Within a given level of disease severity, i.e., number of respiratory disturbances during sleep, inter-individual differences, or differential vulnerability to sleepiness, have been noted in both subjectively measured and objectively measured daytime sleepiness. The reason for this phenomenon remains unclear. Critical to the management of patients with OSA is the understanding of mechanisms associated with the development of daytime sleepiness. We hypothesize that the variance in daytime sleepiness (EDS)will have a substantial trait component in addition to state-related factors among patients with equivalent levels of OSA severity. To systematically identify sources of EDS variance in sleepy and non-sleepy OSA patients, the specific aims of this study will determine: 1) state-specific variance related to sleep duration, obesity and fat distribution, specific comorbidities, and use of certain medications; 2) mis-estimation of severity of sleep disordered breathing from night-to-night variability in respiratory disturbances; 3) underlying trait associated with differential vulnerability to the sleepiness-producing effects of OSA. Using actigraphy and diaries to document sleep duration and both objective and subjective evaluations of sleepiness, Protocol A will classify 260 newly diagnosed OSA subjects as sleepy vs. non-sleepy and will document inter-individual differences in sleepiness among patients with similar disease severity caused by sleep history, obesity and fat distribution, specific comorbidities, and use of certain medications. Controlling for the variance identified in Protocol A, Protocol B will determine the degree to which inter-individual differences in sleepiness in 180 untreated OSA subjects with similar disease severity is a consequence of night-to-night variability in the occurrence of sleep disordered breathing documented by 7 consecutive nights of home sleep studies. Such night-to-night variability would reduce the reliability of single night determinations of apnea severity. Finally, in Protocol C we will determine if inter-individual differences in sleepiness remain after accounting for the variance explained by the clinical factors identified in Protocol A and the variance explained by mis-estimation of severity of sleep disordered breathing documented in Protocol B. In Protocol C, 60 patients (30 sleepy, 30 non-sleepy) will be matched on initial apnea severity and a set of a priori sleepiness factors will undergo 38 hrs of sleep deprivation in a laboratory to determine the existence of an underlying trait for daytime sleepiness.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of CPAP on Functional Outcomes in Milder OSA
  • 批准号:
    6793277
  • 项目类别:
  • 资助金额:
    $61.24万
  • 财政年份:
    2003
  • 负责人:
    TERRI Elizabeth WEAVER
  • 依托单位:
Impact of CPAP on Functional Outcomes in Milder OSA
  • 批准号:
    6600179
  • 项目类别:
  • 资助金额:
    $68.16万
  • 财政年份:
    2003
  • 负责人:
    TERRI Elizabeth WEAVER
  • 依托单位:
Impact of CPAP on Functional Outcomes in Milder OSA
  • 批准号:
    6896584
  • 项目类别:
  • 资助金额:
    $60.81万
  • 财政年份:
    2003
  • 负责人:
    TERRI Elizabeth WEAVER
  • 依托单位:
MECHANISMS OF DIFFERENTIAL SLEEPINESS IN SLEEP APNEA
  • 批准号:
    6716888
  • 项目类别:
  • 资助金额:
    $37.98万
  • 财政年份:
    2003
  • 负责人:
    TERRI Elizabeth WEAVER
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: